PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Chris Paquette, Founder & CEO, DeepIntent as the 2020 Trailblazer Vanguard Award winner.
Chris Paquette is Chief Executive Officer of DeepIntent, a marketing technology company he co-founded on the principle that digital media can influence positive health outcomes. MarketMatch®, the company’s healthcare technology platform, currently supports 20 major pharmaceutical companies and dozens of media agencies to advertise more than 200 healthcare brands.
“It is an honor for our work to be recognized with this prestigious award. Our mission to measurably improve patient outcomes through the artful combination of data and media is one that cannot be accomplished alone,” said Paquette. “Our clients, our partners, and the entire DeepIntent team have supported our relentless pursuit of this vision over the past four years, so I thank them for their continued belief in me and our company.”
Since 2009, the PM360 Trailblazer Awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. The Vanguard Award is given to an industry pioneer who developed a new service, strategy, product, or technology that greatly impacted the industry.
“Even as programmatic advertising was rapidly being adopted by other industries, marketers were still hesitant to embrace this new technology. But Chris’ innovation went a long way towards changing that,” says Anna Stashower, CEO and Publisher of PM360. “In developing a healthcare-specific programmatic platform, Chris offered the marketers in our industry the security, speed, and scale they were waiting for. Now, programmatic has become a key tool for our industry, and its use is only growing.”
In total, 47 winners were honored during a virtual awards ceremony on October 1, 2020. The winners will be featured in the October issue of PM360 and on www.pm360online.com.
# # #
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
